{"id":"W2157759118","doi":"10.1212/wnl.0b013e3182698c64","title":"Disease-modifying drugs for multiple sclerosis in pregnancy","year":2012,"lang":"en","type":"review","venue":"Neurology","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Schweizerische Multiple Sklerose Gesellschaft; Multiple Sclerosis Trust; Multiple Sclerosis Society of Canada; Biogen; Michael Smith Health Research BC; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; University of British Columbia; Multiple Sclerosis Society","keywords":"Glatiramer acetate; Medicine; Natalizumab; Pregnancy; Fingolimod; Birth weight; Obstetrics; Low birth weight; Pediatrics; Discontinuation; Cohort study; Multiple sclerosis; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003797545,0.0007923598,0.00323293,0.009841349,0.0004533989,0.001393427,0.0009330075,0.00141442,0.003030881],"category_scores_gemma":[0.01797456,0.0004685741,0.002216912,0.008777428,0.0004747995,0.001311364,0.0008064044,0.0005047048,0.0003540915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001406083,"about_ca_system_score_gemma":0.004808854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002199068,"about_ca_topic_score_gemma":0.005741687,"domain_scores_codex":[0.9963745,0.0009245824,0.00177962,0.0002340854,0.000595046,0.00009210318],"domain_scores_gemma":[0.9829054,0.01020786,0.005690966,0.0001708779,0.0008963021,0.0001285651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000599175,0.00003805919,0.006665283,0.8232375,0.005190412,0.0009461213,0.0002850418,0.0001055973,0.0006846187,0.0004459836,0.003381775,0.1584204],"study_design_scores_gemma":[0.0004567657,0.0008176615,0.02306034,0.8656756,0.03058745,0.005758154,0.0004736605,0.0001146136,0.000563478,0.0005524966,0.0719003,0.00003938254],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001374329,0.9976609,0.00006976421,0.0001799916,0.0000709525,0.00008920927,0.0002187649,0.000003083794,0.0003331408],"genre_scores_gemma":[0.01668238,0.9812472,0.0007002568,0.0004957067,0.0001639001,0.0002473399,0.0002846349,0.000002317776,0.000176247],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009841349,"threshold_uncertainty_score":0.02008361,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1268651751819757,"score_gpt":0.3089392886387552,"score_spread":0.1820741134567796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}